AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Trial: 12206794
Drug: Intramuscular administration
RxNorm normalized name: Japanese Encephalitis vaccine for intramuscular administration
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intramuscular administration of dystrophin cDNA
Trial: 7907098
Drug: Antipsychotic withdrawal
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Antipsychotic withdrawal (n = 64)
Trial: 7907098
Drug: Continued use
RxNorm normalized name: Ivy Dry Super Continuous Spray
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Continued use of antipsychotics (n = 207)
Trial: 28235817
Drug: Involvement of
RxNorm normalized name: OIL OF CAMPHOR
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Involvement of posterior limb of internal capsule
Trial: 28235817
Drug: ICH encompassing
RxNorm normalized name: SODIUM CHLORIDE 5 mg in 1 mL / MALACHITE GREEN 5 mg in 1 mL TOPICAL SOLUTION [Nox-Ich]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: ICH encompassing thalamus and posterior limb of internal capsule
Trial: 24436950
Drug: Periodontal nonsurgical
RxNorm normalized name: lidocaine
DrugBank: Lidocaine (DB00281)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Periodontal nonsurgical treatment including oral hygiene instruction and scaling and root planing
Trial: 24436950
Drug: Oral hygiene
RxNorm normalized name: HYDROGEN PEROXIDE 2.94 mL in 2.94 mL ORAL SPRAY [OROXID Forte Oral Hygiene]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral hygiene instruction only
Trial: 17062645
Drug: Solution-Finding Approach
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Solution-Finding Approach (SFA)
Trial: 10580352
Drug: sulodexide (600
FDA approved: no
EMA approved: no
PMDA approved: no
Description: sulodexide (600 lipoprotein lipase releasing units [LRU] by im route per day for 30 consecutive days, followed by 500 LRU by oral route per day for a further 30 days)
Trial: 10580352
Drug: standard treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: standard treatment (cleansing with physiological solution and elastic compression with short‐extensibility, removable bandages)
Trial: 9772600
Drug: Xinjikang capsule
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Xinjikang capsule (XJK)
Trial: 1927852
Drug: Low-dose amiodarone
RxNorm normalized name: ethinyl estradiol
DrugBank: Ethinylestradiol (DB00977)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Low-dose amiodarone (400 mg/day for 4 weeks, then 200 mg/day)
Trial: 1927852
Drug: Low-dose amiodarone
RxNorm normalized name: ethinyl estradiol
DrugBank: Ethinylestradiol (DB00977)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Low-dose amiodarone (with >75% reduction in ectopy)
Trial: 31455688
Drug: 0 g
RxNorm normalized name: Co Q-10 Gummies
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 0 g fat
Trial: 31455688
Drug: 20 g
RxNorm normalized name: PEG-20 glyceryl oleate
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 20 g fat
Trial: 7491880
Drug: 40 g
RxNorm normalized name: PEG-40 GLYCERYL STEARATE
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 40 g fat
Trial: 31455688
Drug: 60 g
RxNorm normalized name: aspirin 60 Grains
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 60 g fat
Trial: 26084869
Drug: Intensive glycemic
RxNorm normalized name: Glycerin
DrugBank: Glycerin (DB09462)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intensive glycemic management with continuous insulin infusion (target glucose 4.4‐6.1 mmol/l)
Trial: 26084869
Drug: Conventional glycemic
RxNorm normalized name: Glycerin
DrugBank: Glycerin (DB09462)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Conventional glycemic management with intermittent bolus insulin (target glucose <11.1 mmol/l)
Trial: 24631949
Drug: NEPA (NETU
FDA approved: no
EMA approved: no
PMDA approved: no
Description: NEPA (NETU 300 mg + PALO 0.50 mg) with oral dexamethasone (DEX)
Trial: 19604523
Drug: L-carnitine 2
RxNorm normalized name: L-Carnitine 250mg Oral capsule
FDA approved: no
EMA approved: no
PMDA approved: no
Description: L-carnitine 2 g/d and simvastatin 20 mg
Trial: 19604523
Drug: simvastatin monotherapy
RxNorm normalized name: Simvastatin
DrugBank: Simvastatin (DB00641)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: simvastatin monotherapy 20 mg
Trial: 16824762
Drug: Gait training
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Gait training with functional neuromuscular stimulation (FNS) using intramuscular (IM) electrodes
Trial: 15047004
Drug: Serum alkaline
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Serum alkaline phosphatase and intact parathyroid hormone levels
Trial: 8024910
Drug: Beta 1
RxNorm normalized name: Beta 1 Kit
DrugBank: Betamethasone (DB00443)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Beta 1 blocker (metoprolol)
Trial: 2688940
Drug: Qigong therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Qigong therapy with regularly antihypertensive drug taking (n = 50)
Trial: 2688940
Drug: Control group
RxNorm normalized name: meningococcal group B vaccine Prefilled Syringe [Trumenba]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control group with regularly antihypertensive drug taking only (n = 50)
Trial: 31229087
Drug: Carotenoid-rich 'matrix-free'
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Carotenoid-rich 'matrix-free' formulation (0.8 mg sapotexanthin, 1.2-1.5 mg cryptocapsin)
Trial: 31229087
Drug: Fresh Mamey
RxNorm normalized name: Peroxi-Fresh
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Fresh Mamey sapote fruit (0.8 mg sapotexanthin, 1.2-1.5 mg cryptocapsin)
Trial: 31229087
Drug: Both test
RxNorm normalized name: mumps skin test antigen
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Both test meals (fresh fruit and matrix-free formulation)
Trial: 31229087
Drug: Carotenoid-rich 'matrix-free'
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Carotenoid-rich 'matrix-free' formulation
Trial: 23286463
Drug: Computerized treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Computerized treatment for insomnia
Trial: 21569488
Drug: Group Cognitive
RxNorm normalized name: Streptococcus viridans group
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Group Cognitive Behavioural Therapy (CBT) for 12 weeks
Trial: 12032583
Drug: High-dose intravenous
FDA approved: no
EMA approved: no
PMDA approved: no
Description: High-dose intravenous immunoglobulin G (IVIg)
Trial: 10190913
Drug: Inhaled nitric
RxNorm normalized name: nitric oxide Inhalant Product
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Inhaled nitric oxide (iNO) therapy (10 ppm)
Trial: 31792856
Drug: 15‐keto fluprostenol
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 15‐keto fluprostenol (35 μg/ml)
Trial: 25519996
Drug: Androgen deprivation
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Androgen deprivation therapy (ADT) alone (group B)
Trial: 24079282
Drug: Extended-release niacin
RxNorm normalized name: niacin Extended Release Oral Capsule
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Extended-release niacin (0.5 g/d for 3 weeks, then 1 g/d)
Trial: 21334569
Drug: Combination therapy
RxNorm normalized name: REGN10933+REGN10987 combination therapy
DrugBank: Anti-SARS-CoV-2 REGN-COV2 (DB15691)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combination therapy (alternative SSRI plus CBT)
Trial: 21334569
Drug: Combination therapy
RxNorm normalized name: REGN10933+REGN10987 combination therapy
DrugBank: Anti-SARS-CoV-2 REGN-COV2 (DB15691)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combination therapy (venlafaxine plus CBT)
Trial: 21334569
Drug: Medication mono-therapy
RxNorm normalized name: tiotropium bromide mono
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Medication mono-therapy
Trial: 19243423
Drug: Levetiracetam (40
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Levetiracetam (40 mg/kg/day for age 1 to <6 months; 50 mg/kg/day for age >or=6 months to <4 years)
Trial: 17579892
Drug: Combination of
RxNorm normalized name: combination of rauwolfia alkaloids and diuretics incl. other combinations
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combination of flaxseed (FS) with soy protein or genistein (GEN) with enterodiol (END) and enterolactone (ENL)
Trial: 14758212
Drug: Fibrin glue-anchored
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Fibrin glue-anchored Integra with postoperative negative-pressure therapy
Trial: 7696887
Drug: Nandrolone decanoate
RxNorm normalized name: Nandrolone Decanoate
DrugBank: Nandrolone decanoate (DB08804)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Nandrolone decanoate (50 mg every 3 weeks)
Trial: 7696887
Drug: 1-alpha-hydroxy-calciferol (1
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 1-alpha-hydroxy-calciferol (1 microgram daily)
Trial: 7696887
Drug: Placebo (inactive
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo (inactive drug)
Trial: 3229387
Drug: Large-volume group
RxNorm normalized name: Streptococcus viridans group
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Large-volume group (LVG) injected with up to 30 ml per session
Trial: 3229387
Drug: Small-volume group
RxNorm normalized name: Streptococcus viridans group
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Small-volume group (SVG) injected with up to 15 ml per session
Trial: 27515872
Drug: Withania somnifera
RxNorm normalized name: WITHANIA SOMNIFERA
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Withania somnifera extract (120 mg/day), n = 15
Trial: 24974901
Drug: 20 ml
RxNorm normalized name: Exact-Med, 20 mL
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 20 ml levobupivacaine 0.5%
Trial: 24974901
Drug: 20 ml
RxNorm normalized name: Exact-Med, 20 mL
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 20 ml saline 0.9% (control group)
Trial: 22490197
Drug: Compound whole
RxNorm normalized name: BENZOIN COMPOUND
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Compound whole grain and health education
Trial: 20537611
Drug: No treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: No treatment (n = 12)
Trial: 7664702
Drug: Propofol 0.6
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Propofol 0.6 mg/kg
Trial: 28506854
Drug: Solifenacin oral
RxNorm normalized name: solifenacin Oral Tablet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Solifenacin oral suspension
Trial: 21804501
Drug: S. boulardii
RxNorm normalized name: Lactobac. plantarum/S. boulardii/Pediococcus acidilactici 8 billion cell ORAL CAPSULE,DELAYED RELEASE (ENTERIC COATED)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: S. boulardii 250 mg twice daily orally for one month
Trial: 11294478
Drug: Long-term lithium
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Long-term lithium treatment (>6 months)
Trial: 11294478
Drug: Short-term lithium
RxNorm normalized name: hydrogen peroxide
DrugBank: Hydrogen peroxide (DB11091)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Short-term lithium treatment (<6 months)
Trial: 29684148
Drug: JNJ‐53718678 75
FDA approved: no
EMA approved: no
PMDA approved: no
Description: JNJ‐53718678 75 mg
Trial: 29684148
Drug: JNJ‐53718678 200
FDA approved: no
EMA approved: no
PMDA approved: no
Description: JNJ‐53718678 200 mg
Trial: 29684148
Drug: JNJ‐53718678 500
FDA approved: no
EMA approved: no
PMDA approved: no
Description: JNJ‐53718678 500 mg
Trial: 29684148
Drug: JNJ‐53718678 (all
FDA approved: no
EMA approved: no
PMDA approved: no
Description: JNJ‐53718678 (all doses)
Trial: 22573470
Drug: ENABLE II
FDA approved: no
EMA approved: no
PMDA approved: no
Description: ENABLE II concurrent oncology palliative care intervention
Trial: 21914041
Drug: Lubiprostone (48
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Lubiprostone (48 μg day(-1) for 14 days)
Trial: 17023239
Drug: Heat wrap
RxNorm normalized name: Softheat Ultra Back Heat Wrap
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Heat wrap (treatment study, n=16)
Trial: 14605043
Drug: Tiotropium 18
RxNorm normalized name: TIOTROPIUM 18MCG CAP,INHL,6
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Tiotropium 18 micro g/d
Trial: 8981288
Drug: Fluid Replacement
RxNorm normalized name: amniotic fluid (bovine)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Fluid Replacement Trial (FR-trial) with water bolus of 3.0 ml kg‐1 body mass pre-exercise and 2.0 ml kg‐1 body mass every 15 min during exercise
Trial: 3026273
Drug: Perindopril 4.8
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Perindopril 4.8 mg
Trial: 15570642
Drug: Low level
RxNorm normalized name: low-density polyethylene
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Low level laser therapy
Trial: 3307570
Drug: Both groups
RxNorm normalized name: Streptococcus viridans group
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Both groups with initial EVLW > 14 ml/kg
Trial: 28173855
Drug: Treatment for
RxNorm normalized name: Hair Regrowth Treatment For Men
DrugBank: Minoxidil (DB00350)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Treatment for psychosocial distress
Trial: 16940405
Drug: Oseltamivir 75
RxNorm normalized name: oseltamivir 75 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oseltamivir 75 mg (single oral dose)
Trial: 11502787
Drug: Hormone replacement
RxNorm normalized name: Parathyroid Hormone
DrugBank: Parathyroid hormone (DB05829)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Hormone replacement therapy/estrogen replacement therapy (conjugated estrogens 0.625 mg daily + medroxyprogesterone acetate 2.5 mg daily)
Trial: 11502787
Drug: Combination of
RxNorm normalized name: combination of rauwolfia alkaloids and diuretics incl. other combinations
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combination of hormone replacement therapy/estrogen replacement therapy + calcitriol
Trial: 11502787
Drug: Hormone replacement
RxNorm normalized name: Parathyroid Hormone
DrugBank: Parathyroid hormone (DB05829)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Hormone replacement therapy/estrogen replacement therapy alone
Trial: 11502787
Drug: Combination therapy
RxNorm normalized name: REGN10933+REGN10987 combination therapy
DrugBank: Anti-SARS-CoV-2 REGN-COV2 (DB15691)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combination therapy (in adherent women)
Trial: 3322468
Drug: Fluoxetine (mean
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Fluoxetine (mean dose 73 mg each morning)
Trial: 3322468
Drug: Amitriptyline (mean
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Amitriptyline (mean dose 122 mg at night)
Trial: 29466533
Drug: Clinician coaching
RxNorm normalized name: DuoCare Clinical
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Clinician coaching sessions (dosage)
Trial: 29466533
Drug: Interaction between
RxNorm normalized name: hydroquinone
DrugBank: Hydroquinone (DB09526)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Interaction between patient and clinician dosage
Trial: 26827293
Drug: Standard treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Standard treatment plus practice quitting program (N = 46)
Trial: 26827293
Drug: Standard treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Standard treatment (N = 47)
Trial: 22650122
Drug: Routine acupuncture
RxNorm normalized name: Peace Out Acne Hero Routine KIT
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Routine acupuncture therapy at Shenshu (BL 23)
Trial: 18399768
Drug: Iodized oil
RxNorm normalized name: ethiodized oil
DrugBank: Ethiodized oil (DB00965)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Iodized oil administered orally
Trial: 11135715
Drug: Intramuscular rapacuronium
RxNorm normalized name: rapacuronium
DrugBank: Rapacuronium (DB04834)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Intramuscular rapacuronium 2.8 mg/kg in infants
Trial: 11135715
Drug: Intramuscular rapacuronium
RxNorm normalized name: rapacuronium
DrugBank: Rapacuronium (DB04834)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Intramuscular rapacuronium 4.8 mg/kg in children
Trial: 11135715
Drug: Intramuscular rapacuronium
RxNorm normalized name: rapacuronium
DrugBank: Rapacuronium (DB04834)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Intramuscular rapacuronium (both doses)
Trial: 7605424
Drug: Control patients
RxNorm normalized name: patent blue violet
DrugBank: Patent Blue (DB13967)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control patients on warfarin (n = 31)
Trial: 2731163
Drug: Oral supplementation
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral supplementation with beta-carotene (90 mg twice weekly for 4 weeks)
Trial: 31139989
Drug: Anti-fog solution
RxNorm normalized name: Anti Bac
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Anti-fog solution
Trial: 29739378
Drug: Serum 25-hydroxyvitamin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Serum 25-hydroxyvitamin D concentrations ≥30 ng/ml
Trial: 29739378
Drug: Serum 25-hydroxyvitamin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Serum 25-hydroxyvitamin D concentrations <30 ng/ml
Trial: 27271833
Drug: Interferential currents
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Interferential currents for psoriasis treatment
Trial: 27271833
Drug: Standard medicamentous
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Standard medicamentous therapy for psoriasis treatment
Trial: 27271833
Drug: Interferential currents
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Interferential currents for eczema treatment
Trial: 27271833
Drug: Standard medicamentous
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Standard medicamentous therapy for eczema treatment
Trial: 25331573
Drug: Antibiotic prescribing
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Antibiotic prescribing
Trial: 25331573
Drug: Antibiotic-resistant isolates
RxNorm normalized name: ISOLATE
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Antibiotic-resistant isolates
Trial: 21028985
Drug: High-dose artesunate
RxNorm normalized name: Artesunate
DrugBank: Artesunate (DB09274)
FDA approved: yes
EMA approved: yes
PMDA approved: no
Description: High-dose artesunate therapy (4 mg/kg/day orally for 7 days)
Trial: 15811479
Drug: Manidipine 10
RxNorm normalized name: manidipine 10 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Manidipine 10 mg once daily for 24 weeks
Trial: 15811479
Drug: Enalapril 10
RxNorm normalized name: enalapril 10 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Enalapril 10 mg once daily for 24 weeks
Trial: 8974213
Drug: Fluvastatin therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Fluvastatin therapy (20 mg twice daily)
Trial: 8974213
Drug: Open-label adjunctive
RxNorm normalized name: strontium chloride, 89Sr-labeled
DrugBank: Strontium chloride Sr-89 (DB09498)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Open-label adjunctive cholestyramine (for patients with mean prerandomization LDL cholesterol of 160 mg/dL or higher)
Trial: 14621733
Drug: Calcium antagonists
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Calcium antagonists (CATs)
Trial: 3830764
Drug: Diltiazem 120
RxNorm normalized name: diltiazem 120 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Diltiazem 120 mg every 8 hours for three consecutive days
Trial: 3830764
Drug: Placebo administered
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo administered with the same regimen
Trial: 30819640
Drug: Pharmacist-provided medication
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Pharmacist-provided medication therapy management program
Trial: 18269774
Drug: Albumin-bound paclitaxel
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Albumin-bound paclitaxel 100 mg/m2
Trial: 18269774
Drug: Albumin-bound paclitaxel
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Albumin-bound paclitaxel 125 mg/m2
Trial: 16223400
Drug: Bupivacaine 0.25%
RxNorm normalized name: BUPIVACAINE 0.25%/NS INJ 400ML
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Bupivacaine 0.25% plus 0.5 mg/kg ketamine
Trial: 16223400
Drug: Ropivacaine 0.2%
RxNorm normalized name: ROPivacaine 0.2% injectable solution
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ropivacaine 0.2% plus 0.5 mg/kg ketamine
Trial: 9163650
Drug: Isotonic saline
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Isotonic saline with 2 L x min(‐1) oxygen
Trial: 9163650
Drug: 10 mg
RxNorm normalized name: biotin 10 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 10 mg morphine with 2 L x min(‐1) oxygen
Trial: 9163650
Drug: 20 mg
RxNorm normalized name: urea 20 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 20 mg morphine with 2 L x min(‐1) oxygen
Trial: 9163650
Drug: 10 mg
RxNorm normalized name: biotin 10 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 10 mg morphine without oxygen (prongs fixed, no flow)
Trial: 1973472
Drug: Methotrexate 15
RxNorm normalized name: methotrexate 15 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Methotrexate 15 mg weekly
Trial: 4571398
Drug: Higher dose
RxNorm normalized name: BENZOCAINE 50 mg in 1 mL TOPICAL GEL [HIGHER CONTROL Male Climax Control Lubricating]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Higher dose of terbutaline (0.075 mg/kg)
Trial: 28768263
Drug: Saline rectal
RxNorm normalized name: Ready To Use Saline Rectal Enema
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Saline rectal washout (RW)
Trial: 28768263
Drug: Glycerin suppositories
RxNorm normalized name: Glycerin Suppositories
DrugBank: Glycerin (DB09462)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Glycerin suppositories (GS)
Trial: 25900749
Drug: Dalteparin 5000
RxNorm normalized name: dalteparin 5000 intl units/0.2 mL subcutaneous solution
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Dalteparin 5000 units once daily for 2 weeks
Trial: 20848523
Drug: Traditional non-biologic
RxNorm normalized name: Tavist Non-Sedating
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Traditional non-biologic therapies
Trial: 9115917
Drug: Water exposure
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Water exposure (15 min twice daily for 2 weeks)
Trial: 3310576
Drug: Diltiazem (mean
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Diltiazem (mean 216 mg/day)
Trial: 3310576
Drug: Atenolol (mean
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Atenolol (mean 80 mg/day)
Trial: 15458233
Drug: LIG-2 (1%w/w
FDA approved: no
EMA approved: no
PMDA approved: no
Description: LIG-2 (1%w/w IDU in 5%w/w HPMC K4M gel base)
Trial: 15458233
Drug: LIG-1 (1%w/w
FDA approved: no
EMA approved: no
PMDA approved: no
Description: LIG-1 (1%w/w IDU in 2%w/w HPMC K4M gel base)